(DMAC) Diamedica Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Diamedica Therapeutics | (DMAC) share price targets
Complete technical analysis of Diamedica Therapeutics (DMAC) by charts plus indicators, forecast predictions and share price targets for Diamedica Therapeutics (DMAC)
Diamedica Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-31 View latest technical analysis
10 day averaged volume of Diamedica Therapeutics is 29320
| Date | Daily Closing Price | Open | High | Low | Volume |
| 31 Thu Oct 2024 | 4.37 | 4.34 | 4.48 | 4.18 | 1.579 times |
| 30 Wed Oct 2024 | 4.36 | 4.33 | 4.40 | 4.26 | 0.819 times |
| 29 Tue Oct 2024 | 4.32 | 4.30 | 4.40 | 4.30 | 0.849 times |
| 28 Mon Oct 2024 | 4.30 | 4.39 | 4.44 | 4.27 | 1.286 times |
| 25 Fri Oct 2024 | 4.39 | 4.34 | 4.43 | 4.26 | 1.364 times |
| 24 Thu Oct 2024 | 4.34 | 4.31 | 4.36 | 4.16 | 1.313 times |
| 23 Wed Oct 2024 | 4.38 | 4.30 | 4.48 | 4.23 | 1.739 times |
| 22 Tue Oct 2024 | 4.30 | 4.27 | 4.30 | 4.21 | 0.593 times |
| 21 Mon Oct 2024 | 4.29 | 4.29 | 4.30 | 4.23 | 0.44 times |
| 18 Fri Oct 2024 | 4.34 | 4.25 | 4.36 | 4.21 | 0.75 times |
My analysis of stock is bearish for shortterm, and stock might move down till 4.3 or till 4.2. Use a stoploss of 4.38 and if the stock hits stoploss, then it can shoot up till 4.47
Share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Target | 2.14 |
| Downside Target | 2.65 |
| Downside Target | 3.24 |
| Downside Target | 3.76 |
| Downside Target | 4.07 |
| Upside Target | 4.48 |
| Upside Target | 4.50 |
| Upside Target | 4.77 |
| Upside Target | 4.95 |
Intraday share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Intraday Target | 4.21 |
| Downside Intraday Target | 4.04 |
| Upside Intraday Target | 4.51 |
| Upside Intraday Target | 4.64 |
| Downside Intraday Target | 4.34 |
Weekly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 31 Thu Oct 2024 | 4.37 | 4.39 | 4.48 | 4.18 | 0.832 times |
| 25 Fri Oct 2024 | 4.39 | 4.29 | 4.48 | 4.16 | 0.913 times |
| 18 Fri Oct 2024 | 4.34 | 4.30 | 4.50 | 4.21 | 0.409 times |
| 11 Fri Oct 2024 | 4.25 | 4.46 | 4.77 | 4.18 | 2.266 times |
| 04 Fri Oct 2024 | 4.36 | 4.15 | 4.48 | 4.11 | 0.812 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 31 Thu Oct 2024 | 4.37 | 4.17 | 4.77 | 4.11 | 0.797 times |
| 30 Mon Sep 2024 | 4.19 | 4.01 | 4.95 | 3.76 | 1.604 times |
| 30 Fri Aug 2024 | 3.93 | 3.46 | 4.07 | 3.25 | 0.55 times |
| 31 Wed Jul 2024 | 3.28 | 2.95 | 3.81 | 2.65 | 0.868 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Diamedica Therapeutics (DMAC)
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Diamedica Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.35 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Diamedica Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.35 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.